We also explain substitute ways for CRISPR–Cas9-mediated deletion of putative tumor suppressors. Mimicking genetic modifications generally found in lymphoid malignancies results in immortalized growth in vitro, although engraftment into immunodeficient mice generates genetically customized, synthetic models of human lymphoma. The protocol is simple and cheap and may be executed in http://www.pearltrees.com/bluejet4